Your session is about to expire
← Back to Search
Cross over Device (PCD or Dayspring - alternate to first group) for Leg Lymphedema (TEAYS Trial)
TEAYS Trial Summary
This trial is to compare the effectiveness of the Koya device to a standard compression device for people with lymphedema.
- Leg Lymphedema
- Lymphedema
- Chronic Venous Insufficiency
- Venous Insufficiency
- Lower Limb Lymphedema
TEAYS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TEAYS Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this clinical trial have an age restriction, and if so what is the threshold?
"This clinical trial is searching for participants aged 18 to 100 years. Additionally, there are 4 separate trials available that target patients younger than 18 and another one hundred studies intended for those 65 and older."
Is there an open enrollment period for this clinical trial?
"Confirming, clinicaltrials.gov displays that this medical trial is presently engaging participants. It was initially posted on September 6th 2022 and has been recently changed on November 9th 2022. 50 test subjects are required between a single location."
How many participants are currently included in this medical experiment?
"Affirmative. According to clinicaltrials.gov, this trial is still underway and recruiting participants since its launch on September 6th 2022. 50 individuals are required at one medical centre for the trial; it was last updated November 9th of the same year."
Who meets the criteria to take part in this clinical experiment?
"Eligible candidates for this trial must be between 18 and 100 years of age, with lower extremity difficulties. There are 50 open slots in the study."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger